Company: Illumina Inc.
Date of Enforcement Report 12/31/2014
Class lII:
PRODUCT
Illumina MiSeqDx Cystic Fibrosis Clinical Sequencing Assay in vitro diagnostic system for use on the Illumina MiSeqDx Platform. Recall Number Z-0850-2015
REASON
Illumina has confirmed a software limitation with MiSeq Reporter software (version 2.2.31) when using the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay on the MiSeqDx instrument..
RECALLING FIRM/MANUFACTURER
Illumina Inc, San diego, CA, on 11/6/2014. Firm Initiated recall is ongoing.
VOLUME OF PRODUCT IN COMMERCE
19 units
DISTRIBUTION
US: MD, NY Non-US: France
___________________________________
